Brexpiprazole
NDC Package 70710-1449-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Brexpiprazole is a . Marketed by Zydus Pharmaceuticals Usa Inc., this product is identified by NDC 70710-1449 and is authorized under FDA application ANDA213660.

Identification & Billing

NDC Package Code
70710-1449-3
Package Description
30 TABLET in 1 BOTTLE
Product Code
70710-1449
11-Digit Billing Format
70710144903

Clinical Specifications

Proprietary Name
Brexpiprazole
Dosage Form
-

Regulatory & Marketing

Labeler Name
Zydus Pharmaceuticals Usa Inc.
FDA Application #
ANDA213660
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-25-2025
End Marketing Date
03-27-2025
Listing Expiration
03-27-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70710-1449-3 identifies a specific commercial package of 30 tablet in 1 bottle of Brexpiprazole, labeled by Zydus Pharmaceuticals Usa Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Zydus Pharmaceuticals Usa Inc. on March 25, 2025. The current certification is valid through March 27, 2025.

How is this Zydus Pharmaceuticals Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710144903. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70710-1449-3
11-Digit CMS (5-4-2)
70710-1449-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.